Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE)

Overview

Infants born with congenital defects may require major surgery in the neonatal period. These infants are at risk for neurodevelopmental impairments. Additionally, their parents are at higher risk for adverse mental health outcomes. Early relationships are essential to healthy growth and development in all children. Relationships between parents and infants born with a congenital defect are negatively impacted by separation due to hospitalization; parental and infant stress exposures; and alterations in infant behavior and parental mental health. Benefits of H-HOPE intervention on infant neurodevelopment outcomes have been observed in healthy and at-risk term and preterm infant populations but never evaluated in infants with congenital defects. The purpose of this study is to examine impact of the Hospital to Home: Optimizing Preterm Infant Environment (H-HOPE) intervention versus standard ICU care for infants born with a congenital defect requiring neonatal surgery, and their parents. The main questions to be answered include: 1. Does H-HOPE improve pre-feeding state and behavior, oral feeding progression, and growth in infants born with a congenital defect requiring neonatal surgery? 2. Does H-HOPE neurodevelopmental outcomes in infants born with a congenital defect requiring neonatal surgery? 3. Does H-HOPE improve parental mental health outcomes among parents of infants born with a congenital defect requiring neonatal surgery? 4. Does H-HOPE improve parent-infant interactions among infants born with a congenital defect requiring neonatal surgery and their parents? 5. Does H-HOPE improve neuroendocrine function among infants born with a congenital defect requiring neonatal surgery and their parents? 6. Do parents of infants born with congenital defects requiring surgery experience participating in the H-HOPE intervention positively? Results of this study may provide preliminary evidence supporting use of H-HOPE to positively impact short- and long-term outcomes for these infants and their parents.

Primary Objectives: Primary objective of this study is to examine impact of H-HOPE intervention versus standard ICU care on early feeding, growth and neurodevelopment for infants born with a congenital defect requiring major surgery. Hypotheses include: H1. Infants born with a congenital defect and receiving H-HOPE intervention versus standard care will have more favorable outcomes at ICU discharge and at 3-4 months including: H1.1 Improved behavioral organization, measured by pre-feeding state and behavioral cues. H1.2 Improved neuroendocrine function measured by salivary cortisol reactivity. H1.3 More rapid oral feeding progression and growth. H1.4 Improved neurodevelopment, measured by Test of Infant Motor Performance, Ages and Stages Questionnaire, and Parent Report of Oral Feeding at Home survey. Secondary Objectives: Secondary objectives of study are to evaluate impact of H-HOPE intervention on parents' mental health, parents' neuroendocrine outcomes at ICU discharge, and parent-infant interactions among parents of infants born with a congenital defect requiring surgery. Secondary objectives include exploring potential relationships between parental living conditions and parent-infant outcomes related to H-HOPE. Hypotheses include: H2. Having received H-HOPE intervention, parents of infants born with a congenital defect will have more favorable outcomes, including: H2.1 Improved mental health, measured by perinatal depression, anxiety, and confidence in caregiving scores at ICU discharge, and perinatal PTSD at 3-4 months. H2.2 Improved neuroendocrine function measured by salivary cortisol reactivity. H3. Having received H-HOPE intervention, parent and infant dyads will have more favorable parent-infant interactions during feeding at ICU discharge. H 3.1 Having received H-HOPE intervention, parents will describe positive impacts of intervention on their relationship with the infant. Background: Worldwide an estimated 6% of infants are born with a congenital defect. Congenital defects are structural anomalies that develop prenatally. These defects represent a significant cause of illness, disability, and death among children. Infants born with congenital defects, including congenital heart defects, often require specialized care in intensive care units (ICUs) and major surgery in the neonatal period. US families and the nation share the burden of costs associated with congenital defects that are estimated to be $2.6 billion per year in hospital costs alone. Throughout this application the term congenital defects refers to neonates with a birth defect requiring major surgery. Because significant risks for neurodevelopmental impairments occur in infants with both cardiac and non-cardiac congenital defects, studies focusing on improving their neurodevelopmental outcomes are imperative. Early neurodevelopmental impairments in infants with congenital defects include difficulties with behavioral organization, oral feeding, and growth, delaying hospital progression. Significant numbers of infants with complex CHD will have neurodevelopmental impairments that frequently persist into adolescence and adulthood, including delays in cognitive, motor and language development and psychosocial issues. Cognitive, motor and language delays are observed in 23-25% of one- to three-year-old infants with non-cardiac congenital defects requiring neonatal surgery. Parents of infants born with congenital defects experience higher risks for adverse mental health outcomes, including anxiety, depression, symptoms of trauma and post-traumatic stress disorder (PTSD). In the weeks to months following neonatal surgery to correct CHDs, 25-50% of parents report symptoms of depression and/or anxiety, 11-68% report symptoms consistent with PTSD, and 30-80% report severe psychological distress. These mental health issues may be precipitated by parental stress and grief that are triggered by the infant's diagnosis, the need for early surgery and hospitalization, and the loss of expected parenting experiences. Alterations in early parent-child relationships associated with parental mental health issues may significantly compromise parent and infant outcomes. Frequent, repeated exposures to pain and stress impact neuroendocrine function of infants with congenital defects. Chronic activation of the hypothalamic-pituitary-adrenal axis that is associated with these cumulative exposures may alter baseline infant cortisol levels and cortisol reactivity. Stress can precipitate changes in brain structure and function that are associated with short- and long-term neurodevelopmental impairments. Parents of infants requiring surgery to repair a congenital defect during the neonatal period experience higher levels of stress than parents of healthy infants. These may result in psychological and physiologic stress responses. Elevated cortisol in parents during the post-surgical period is associated with symptoms of post-traumatic stress at 3 months post discharge. Quality of parent-infant interactions influences secure attachment that positively impacts later cognitive, language and social development. Parents and infants born with congenital defects are at risk for developing maladaptive interactive patterns. Parental and infant factors influence the maladaptive interaction patterns observed in this population and contribute to long term outcomes. The Ecobiodevelopmental model explains that early experiences in a child's ecology (social and physical environment) are embedded in their biology, influencing neurodevelopment and health across the lifespan. Early relational health in the form of safe, stable, nurturing relationships are essential to healthy growth and development in all children. Unfortunately, relationships between parents and infants born with a congenital defect are negatively impacted by parental living conditions; separation due to hospitalization; parental and infant stress exposures; and alterations in infant behavior and parental mental health. There is a need for evidence-based interventions targeting early relational health in this population, and studies examining potential interventions targeting both infants and parents should be prioritized. Parent-infant challenges faced by parents and their infants born with a congenital defect can be addressed via interventions that target early relational health. Predominantly studied with preterm infants, the H-HOPE intervention is a multisensory behavioral intervention that supports optimal infant development, parent mental health, parent-infant interactions, and stress reactivity. H-HOPE has two components: Parents+ and Massage+. Trained clinicians provide Parents+ using participatory guidance and experiential learning approaches. During the Parents+ sessions, parents learn infant behavioral cues, and how to read, interpret, and respond to their infant's cues during Massage+. They also learn the Massage+ intervention, which includes the behaviors that parents typically engage in with their infants (auditory, tactile, visual, and vestibular stimuli). After the first Parents+ session, parents begin offering Massage+ to their infants up to two times per day. While administering Massage+, parents assess their infant's behavioral cues and modify their behavior to optimize the infant's behavioral and physiologic responses. Thus, the H-HOPE intervention supports parental engagement and parent-infant interactions with hospitalized infants as parents learn about their infants' behavioral capacity. The H-HOPE intervention has not been implemented in infants born with congenital defects and their parents. This study may add to the existing knowledge related to H-HOPE. Number of Participants: Forty total infants and one or both of their parents will be enrolled in the study. They will be randomly assigned to receive H-HOPE intervention (N=20) or standard ICU care (N=20). Study Intervention: H-HOPE (Hospital to Home: Optimizing Preterm Infant Environment) intervention is a multisensory behavioral intervention. H-HOPE has two components: Parents+ and Massage+. Parents+: Trained study team members will provide Parents+ training. During the Parents+ sessions, parents learn infant behavioral cues, and how to read, interpret, and respond to their infant's cues during Massage+. They also learn the Massage+ intervention. Massage+: A 15-minute, multisensory, behavioral intervention that will be taught to parents during Parents+ sessions and implemented by parents with infants in the intervention group. It includes talking to the baby (30 seconds), massaging the baby (10 minutes; may be adapted to avoid wounds or as tolerated by baby), visual and vestibular stimuli (rocking and showing face for 5 minutes). Parent training will be reinforced regularly. After the infant meets inclusion criteria and parents complete their Parents+ session, parents will begin offering Massage+ to their infants up to 2 times per day. While administering Massage+, parents assess their infant's behavioral cues, modifying as needed to optimize the infant's responses. Bedside nurses, child life specialists and rehabilitative therapists will be trained to provide Massage+ when a parent temporarily cannot be at the bedside (i.e., due to a sibling illness). Control group infants will receive ICU standard care that may include nursing care every 1-4 hours, developmental or rehabilitative therapies, parent presence, parental holding, skin-to-skin care, or other forms of infant massage. Control group parents will be offered an infant care class unrelated to the study that will include information about infant sleep, and movement. Professional staff will be educated to not provide Massage+ for Control group infants. This will be reinforced with the staff and monitored daily for each patient enrolled. Study Procedures: A randomized clinical trial will be conducted. Study procedures are outlined below. Study enrollment may occur when infant is weaning respiratory support and IV pain medications. Once enrolled, families will be randomized to intervention or control groups. Intervention group parents will not participate in Parents+ training but will be offered an infant class unrelated to study intervention. Once enrolled infants are on respiratory support that is \< a nasal cannula at 2 liters and off IV pain medications, intervention group parents will begin providing the Massage+ intervention for their infants 2 times per day, as tolerated. Parents may stop or adjust Massage+ as needed. Control group infants will receive standard ICU care, including standard parent participation activities (holding, skin-to-skin). A bedside study log will be used to document frequency of Massage+ by parents or staff, infant tolerance of Massage+ (intervention group), parent presence, and parent-infant activities for both groups. A general infant care class will also be offered to control parents. Outcomes measures will be completed at ICU discharge and at post-ICU discharge at 3-4 months post-menstrual age.